Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.

Sponsor
Nottingham University Hospitals NHS Trust (Other)
Overall Status
Completed
CT.gov ID
NCT05352789
Collaborator
University of Nottingham (Other), University of Sheffield (Other), Sheffield Teaching Hospitals NHS Foundation Trust (Other)
79
1
17.9
4.4

Study Details

Study Description

Brief Summary

To explore current practices of nutrition and metabolic screening, assessment and management prior to Haematopoietic Stem Cell Transplant (HSCT) in UK and ROI transplant centres.

Nutrition and metabolic parameters assessed in the survey include glycaemic control, lipid function, liver function, nutritional screening, nutritional assessment, nutrition intervention (tube feeding, diet, micronutrient) and exercise.

This work will be used to inform the design of a UK dual centre feasibility study of personalised nutrition and metabolic care for HSCT patients prior to transplantation.

Study Design

Study Type:
Observational
Actual Enrollment :
79 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Exploration of Nutrition and Metabolic Prehabilitation Practices for Haematopoietic Stem Cell Transplant (HSCT) in UK and ROI Transplant Centres: A BSBMT Multi-centre Survey
Actual Study Start Date :
Sep 1, 2020
Actual Primary Completion Date :
Mar 1, 2022
Actual Study Completion Date :
Mar 1, 2022

Outcome Measures

Primary Outcome Measures

  1. To understand the routine screening, assessment and management practices of nutritional and metabolic parameters prior to haematopoeitic stem cell transplantation in UK centres [December 20]

    full survey completion: see parameters below

  2. Differences in frequency of glycaemic screening prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    a) Glycaemic screening will be assessed by 2 responses: How often would you measure blood glucose and urinary glucose prior to HSCT? (likert scale - Always, often, sometimes, rarely, never)

  3. Differences in frequency of assessments of lipid profile screening prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    b. Lipid parameters: How often would you measure blood glucose and urinary glucose prior to HSCT? (likert scale - Always, often, sometimes, rarely, never)

  4. Differences in frequency of assessments of liver and renal function prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    c. Liver and renal function screening frequency will be asked: 1. How often would you measure liver/kidney function as blood samples prior to HSCT? (likert scale - Always, often, sometimes, rarely, never); 2. How often would you measure liver/kidney function using a scan prior to HSCT? (likert scale - Always, often, sometimes, rarely, never)

  5. Differences in nutritional screening and assessment practices done prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    d. Nutritional screening and assessment: Routine inclusion of nutritional screening and assessment practices prior to HSCT will be assessed using 4 mandatory questions, 3 - yes/no/unsure and 1 categorical question. Practical details of strategies of assessment and measurement will be assessed using 5 categorical questions and 6 free text questions.

  6. Differences in body composition assessments given prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    e. Assessment of body composition: Routine inclusion of body composition assessment prior to HSCT will be assessed using 2 mandatory questions, 1 - yes/no/unsure and 1 categorical question. Practical details of strategies of assessment and measurement will be assessed using 2 categorical questions and 3 free text questions.

  7. Differences in dietary advice given prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    f. Dietary advice: Routine inclusion of dietary advice prior to HSCT will be assessed using 3 mandatory questions, 1 - yes/no/unsure and 2 - five point likert scales (definitely = 4, very probably = 3, probably=2, probably not = 1, definitely not =0). Practical details of types of dietary advice and strategies for implementation will be assessed using 2 categorical questions, 2 free text questions and 3 - six point likert scaled consensus statements (Always= 5, very frequently = 4, occasionally = 3, rarely = 2, very rarely = 1, never = 0)

  8. Differences in enteral feeding practices prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    g. Enteral feeding: Routine inclusion of enteral feeding prior to HSCT will be assessed using 2 mandatory questions, 1 - categorical. Practical details of types of enteral feeding tubes 2 questions (1 - categorical questions, 1 free text)

  9. Differences in specialist dietary advice given prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    h. Micronutrient supplementation: Routine inclusion of micronutrient advice prior to HSCT will be assessed using 1 mandatory question, yes/no/unsure format. Practical details of micronutrient supplementation practices using 1 categorical questions and 1 free text question.

  10. Differences in physical assessment, advice and delivery prior to HSCT across UK and ROI HSCT centres and between health professionals [December 20]

    i. Exercise: As part of routine practice how often do patients receive exercise advice prior to HSCT? (likert response: Always, often, sometimes, rarely, never); As part of "routine practice" how often do your patients have their activity levels measured prior to HSCT i.e. questionnaire or physical assessment? response: Always, often, sometimes, rarely, never); and 2 multi select questions to determine professionals delivering care.

Secondary Outcome Measures

  1. To understand perceptions on the role and value of prehabilitation in HSCT [December 20]

    a. Point of effectiveness: using responses from three questions; Do you think prehabilitation should be considered as part of future services for HSCT? (Yes/no/unsure); When in the HSCT pathway do you think a prehabilitation service could be introduced? Assessed via categorical data (Prior to diagnosis, at diagnosis prior to chemotherapy, during induction chemotherapy, end of induction chemotherapy, maintenance chemo, during HSCT assessment clinic, other than listed); Do you think any changes are needed to the Silver et al (2013) prehabilitation definition in order for it to be relevant to HSCT?* (yes/no/unsure); 2 x free text answers for concerns and barriers to implementation.

  2. Perceptions on best composition of prehabilitation programme prior to HSCT. [December 20]

    a) This would be answered with two questions: How important do you think exercise, nutrition and psychological care are in prehabilitation programme for HSCT? (very important, important, moderately important, slightly important, not important) ; Are there any other components that you think should be considered as part of a prehabilitation programme for HSCT? (free text)

  3. Description of current HSCT prehabilitation services in adult services in UK and ROI [December 20]

    2 x single select; What components of prehabilitation does your service include? (nutrition, psychology, exercise, other); Do you have a dedicated prehabilitation service for HSCT at your unit? (yes/no/unsure); Which other components are included as part of your prehabilitation programme for HSCT?

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BSBMT registered adult HSCT centres (including TYA services where patients have opted to be treated in an adult service pathways)

  • Centres delivering either autologous or allogeneic stem cell transplants

Exclusion Criteria:
  • All paediatric HSCT services

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nottingham University Hospitals NHS Trust Nottingham Nottinghamshire United Kingdom NG5 1PB

Sponsors and Collaborators

  • Nottingham University Hospitals NHS Trust
  • University of Nottingham
  • University of Sheffield
  • Sheffield Teaching Hospitals NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nottingham University Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT05352789
Other Study ID Numbers:
  • IDBSBMT
First Posted:
Apr 29, 2022
Last Update Posted:
Apr 29, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nottingham University Hospitals NHS Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 29, 2022